BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3914834)

  • 1. Development of procoagulant binding sites on the platelet surface.
    Bevers EM; Rosing J; Zwaal RF
    Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane involvement in blood coagulation.
    Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
    Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry?
    Verhallen PF; Bevers EM; Comfurius P; Zwaal RF
    Biochim Biophys Acta; 1987 Sep; 903(1):206-17. PubMed ID: 2820487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet procoagulant properties studied with snake venom prothrombin activators.
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    Thromb Haemost; 1987 Jun; 57(3):349-55. PubMed ID: 3310319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet prothrombin converting activity in hereditary disorders of platelet function.
    Bevers EM; Comfurius P; Nieuwenhuis HK; Levy-Toledano S; Enouf J; Belluci S; Caen JP; Zwaal RF
    Br J Haematol; 1986 Jun; 63(2):335-45. PubMed ID: 3718874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity--a comparison with Scott syndrome.
    Weiss HJ; Lages B
    Blood; 1997 Mar; 89(5):1599-611. PubMed ID: 9057642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet prothrombinase in health and disease.
    Crook M
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):167-74. PubMed ID: 2130928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of activated human platelets in prothrombin and factor X activation.
    Rosing J; van Rijn JL; Bevers EM; van Dieijen G; Comfurius P; Zwaal RF
    Blood; 1985 Feb; 65(2):319-32. PubMed ID: 3967085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane phospholipids are the major determinant of the binding site for factor X activating--and prothrombinase complexes at the surface of human platelets.
    Bevers EM; Rosing J; Zwaal RF
    Agents Actions Suppl; 1986; 20():69-75. PubMed ID: 3468783
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in membrane phospholipid distribution during platelet activation.
    Bevers EM; Comfurius P; Zwaal RF
    Biochim Biophys Acta; 1983 Dec; 736(1):57-66. PubMed ID: 6418205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
    Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoride-dependent calcium-induced platelet procoagulant activity shows that calpain is involved in increased phospholipid transbilayer movement.
    Verhallen PF; Bevers EM; Comfurius P; Zwaal RF
    Biochim Biophys Acta; 1988 Jul; 942(1):150-8. PubMed ID: 2838083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder.
    Rosing J; Bevers EM; Comfurius P; Hemker HC; van Dieijen G; Weiss HJ; Zwaal RF
    Blood; 1985 Jun; 65(6):1557-61. PubMed ID: 3995186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity.
    Sims PJ; Wiedmer T; Esmon CT; Weiss HJ; Shattil SJ
    J Biol Chem; 1989 Oct; 264(29):17049-57. PubMed ID: 2793843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of phospholipids in hemostasis].
    Sletnes KE
    Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2238-41. PubMed ID: 8362386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired platelet procoagulant mechanisms in patients with bleeding disorders.
    Weiss HJ
    Semin Thromb Hemost; 2009 Mar; 35(2):233-41. PubMed ID: 19408196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal formation of the prothrombinase complex: factor V deficiency and related disorders.
    Tracy PB; Mann KG
    Hum Pathol; 1987 Feb; 18(2):162-9. PubMed ID: 3804320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet procoagulant activity: physiological significance and mechanisms of exposure.
    Bevers EM; Comfurius P; Zwaal RF
    Blood Rev; 1991 Sep; 5(3):146-54. PubMed ID: 1777747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet procoagulant complex assembly in a tissue factor-initiated system.
    Monroe DM; Roberts HR; Hoffman M
    Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of the binding for prothrombinase at the platelet surface as revealed by lipolytic enzymes.
    Bevers EM; Comfurius P; Zwaal RF
    Eur J Biochem; 1982 Feb; 122(1):81-5. PubMed ID: 7060571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.